Esperion Therapeutics IncNASDAQ:ESPR
- LAST PRICE1.7500
- TODAY'S CHANGE (%)-0.1600 (-8.3770%)
- Bid / Lots1.7400/ 73
- Ask / Lots1.7500/ 110
- Open / Previous Close1.8900 / 1.9100
- Day Range
- 52 Week Range
- Volume2,028,610
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ESPR |
|---|---|---|
| 09:32 ET | 43712 | 1.865 |
| 09:34 ET | 16164 | 1.865 |
| 09:36 ET | 21214 | 1.87 |
| 09:38 ET | 5700 | 1.865 |
| 09:39 ET | 11000 | 1.87 |
| 09:41 ET | 65116 | 1.85 |
| 09:43 ET | 2400 | 1.85 |
| 09:45 ET | 15790 | 1.85 |
| 09:48 ET | 17858 | 1.8424 |
| 09:50 ET | 6400 | 1.85 |
| 09:52 ET | 21364 | 1.85 |
| 09:54 ET | 4639 | 1.85 |
| 09:56 ET | 26976 | 1.855 |
| 09:57 ET | 14288 | 1.8501 |
| 09:59 ET | 2630 | 1.855 |
| 10:01 ET | 3564 | 1.855 |
| 10:03 ET | 1000 | 1.855 |
| 10:06 ET | 3936 | 1.86 |
| 10:08 ET | 3353 | 1.86 |
| 10:10 ET | 2200 | 1.85 |
| 10:12 ET | 997 | 1.855 |
| 10:14 ET | 300 | 1.855 |
| 10:15 ET | 59105 | 1.865 |
| 10:17 ET | 7100 | 1.8601 |
| 10:19 ET | 6503 | 1.865 |
| 10:21 ET | 27955 | 1.85 |
| 10:24 ET | 54002 | 1.845 |
| 10:26 ET | 45774 | 1.85 |
| 10:28 ET | 2000 | 1.8502 |
| 10:30 ET | 92608 | 1.85 |
| 10:32 ET | 15353 | 1.8555 |
| 10:33 ET | 23052 | 1.85 |
| 10:35 ET | 24834 | 1.85 |
| 10:37 ET | 7608 | 1.8599 |
| 10:39 ET | 5702 | 1.855 |
| 10:42 ET | 3926 | 1.855 |
| 10:44 ET | 5104 | 1.86 |
| 10:46 ET | 9542 | 1.855 |
| 10:48 ET | 4335 | 1.855 |
| 10:50 ET | 1021 | 1.8542 |
| 10:51 ET | 1322 | 1.855 |
| 10:53 ET | 2510 | 1.855 |
| 10:55 ET | 4932 | 1.855 |
| 10:57 ET | 40285 | 1.855 |
| 11:00 ET | 1200 | 1.855 |
| 11:02 ET | 610 | 1.855 |
| 11:04 ET | 62287 | 1.8598 |
| 11:06 ET | 305 | 1.855 |
| 11:08 ET | 1450 | 1.855 |
| 11:09 ET | 350 | 1.85 |
| 11:11 ET | 4280 | 1.855 |
| 11:13 ET | 1528 | 1.85 |
| 11:15 ET | 706 | 1.855 |
| 11:18 ET | 2120 | 1.855 |
| 11:20 ET | 4683 | 1.85 |
| 11:22 ET | 480 | 1.855 |
| 11:24 ET | 300 | 1.85 |
| 11:26 ET | 3897 | 1.86 |
| 11:27 ET | 3921 | 1.855 |
| 11:29 ET | 12587 | 1.85 |
| 11:31 ET | 65551 | 1.855 |
| 11:33 ET | 768 | 1.855 |
| 11:36 ET | 4786 | 1.855 |
| 11:38 ET | 985 | 1.85 |
| 11:40 ET | 912 | 1.855 |
| 11:42 ET | 1802 | 1.855 |
| 11:44 ET | 16429 | 1.86 |
| 11:45 ET | 2552 | 1.855 |
| 11:47 ET | 26994 | 1.86 |
| 11:49 ET | 400 | 1.8613 |
| 11:51 ET | 500 | 1.87 |
| 11:54 ET | 1300 | 1.866 |
| 11:56 ET | 13744 | 1.875 |
| 11:58 ET | 1897 | 1.875 |
| 12:00 ET | 1754 | 1.87 |
| 12:02 ET | 1600 | 1.875 |
| 12:03 ET | 900 | 1.87 |
| 12:05 ET | 100 | 1.875 |
| 12:07 ET | 300 | 1.87 |
| 12:09 ET | 1564 | 1.875 |
| 12:12 ET | 494 | 1.87 |
| 12:14 ET | 9015 | 1.86 |
| 12:16 ET | 2214 | 1.86 |
| 12:18 ET | 9870 | 1.855 |
| 12:20 ET | 2042 | 1.85 |
| 12:21 ET | 2079 | 1.855 |
| 12:23 ET | 1053 | 1.855 |
| 12:25 ET | 1131 | 1.855 |
| 12:27 ET | 8559 | 1.855 |
| 12:30 ET | 541 | 1.855 |
| 12:32 ET | 22218 | 1.865 |
| 12:34 ET | 12746 | 1.86 |
| 12:36 ET | 5000 | 1.865 |
| 12:38 ET | 300 | 1.865 |
| 12:39 ET | 1500 | 1.866 |
| 12:41 ET | 300 | 1.87 |
| 12:43 ET | 400 | 1.86 |
| 12:45 ET | 300 | 1.865 |
| 12:48 ET | 735 | 1.86 |
| 12:50 ET | 1200 | 1.865 |
| 12:52 ET | 1490 | 1.87 |
| 12:54 ET | 500 | 1.8688 |
| 12:56 ET | 300 | 1.865 |
| 12:57 ET | 604 | 1.865 |
| 12:59 ET | 1651 | 1.865 |
| 01:01 ET | 646 | 1.865 |
| 01:03 ET | 620 | 1.86 |
| 01:06 ET | 502 | 1.865 |
| 01:08 ET | 1888 | 1.865 |
| 01:10 ET | 6239 | 1.865 |
| 01:12 ET | 500 | 1.865 |
| 01:14 ET | 100 | 1.865 |
| 01:15 ET | 853 | 1.8601 |
| 01:17 ET | 1553 | 1.865 |
| 01:19 ET | 300 | 1.865 |
| 01:21 ET | 600 | 1.865 |
| 01:24 ET | 17288 | 1.855 |
| 01:26 ET | 5338 | 1.855 |
| 01:28 ET | 26641 | 1.85 |
| 01:30 ET | 50466 | 1.84 |
| 01:32 ET | 94939 | 1.8201 |
| 01:33 ET | 12921 | 1.81 |
| 01:35 ET | 7993 | 1.81 |
| 01:37 ET | 26632 | 1.815 |
| 01:39 ET | 13373 | 1.82 |
| 01:42 ET | 47769 | 1.795 |
| 01:44 ET | 54102 | 1.805 |
| 01:46 ET | 44820 | 1.815 |
| 01:48 ET | 60019 | 1.805 |
| 01:50 ET | 35268 | 1.805 |
| 01:51 ET | 29612 | 1.8 |
| 01:53 ET | 4400 | 1.8 |
| 01:55 ET | 1350 | 1.805 |
| 01:57 ET | 600 | 1.8 |
| 02:00 ET | 100 | 1.8 |
| 02:02 ET | 407 | 1.805 |
| 02:04 ET | 1250 | 1.805 |
| 02:06 ET | 41772 | 1.795 |
| 02:08 ET | 82901 | 1.7899 |
| 02:09 ET | 5779 | 1.7879 |
| 02:11 ET | 639 | 1.78 |
| 02:13 ET | 2920 | 1.78 |
| 02:15 ET | 46055 | 1.7614 |
| 02:18 ET | 13449 | 1.755 |
| 02:20 ET | 12558 | 1.755 |
| 02:22 ET | 5938 | 1.755 |
| 02:24 ET | 7300 | 1.7587 |
| 02:26 ET | 700 | 1.75 |
| 02:27 ET | 684 | 1.75 |
| 02:29 ET | 4859 | 1.755 |
| 02:31 ET | 582 | 1.755 |
| 02:33 ET | 1849 | 1.75 |
| 02:36 ET | 10000 | 1.7584 |
| 02:38 ET | 7800 | 1.75 |
Sep 5, 2024
Esperion to Participate in Upcoming 2024 Cantor Global Healthcare Conference, from 8:00AM ET on Thursday Sep 05, 2024 by Dow Jones
8:00AM ET on Thursday Sep 05, 2024 by Dow Jones
Sep 3, 2024
Aug 26, 2024
Esperion to Participate in Upcoming H.C. Wainwright 26th Annual Global Investment Conference, from 8:00AM ET on Monday Aug 26, 2024 by Dow Jones
8:00AM ET on Monday Aug 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Esperion Therapeutics Inc | 374.8M | -2.0x | --- |
Rigel Pharmaceuticals Inc | 241.1M | -17.2x | --- |
Bavarian Nordic A/S | 2.9B | 19.4x | --- |
Lifecore Biomedical Inc | 160.1M | 34.2x | +27.97% |
SIGA Technologies Inc | 563.8M | 6.8x | -28.78% |
Daiichi Sankyo Co Ltd | 70.5B | 42.9x | --- |
Company Information
Esperion Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). The Company's products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company's NEXLETOL and NEXLIZET (bempedoic acid and ezetimibe) tablets are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia (HeFH) or atherosclerotic cardiovascular disease (ASCVD). Its NEXLETOL is an ATP Citrate Lyase (ACL), inhibitor that lowers LDL-C by reducing cholesterol biosynthesis and up-regulating the LDL receptors. Its NUSTENDI contains bempedoic acid and ezetimibe and lowers elevated LDL-C through complementary mechanisms of action by inhibiting cholesterol synthesis in the liver and absorption in the intestine. Its Pipeline product include Next Generation ACLYi.
Contact Information
- Headquarters
- 3891 Ranchero Drive Suite 150, Suite 300ANN ARBOR, MI, United States 32960
- Phone
- 734-887-3903
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- J. Martin Carroll
- President, Chief Executive Officer, Director
- Sheldon Koenig
- Chief Financial Officer
- Benjamin Halladay
- General Counsel
- Benjamin Looker
- Chief Medical Officer
- Joanne Foody
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $374.8M |
|---|---|
Revenue (TTM) | $277.8M |
Shares Outstanding | 196.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.99 |
EPS | $-0.88 |
Book Value | $-3.85 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 1.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -17.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
